Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -910 | 0 | -20,150 | 0 | 0 |
| Depreciation Amortization | 3,320 | 0 | 6,740 | 0 | 0 |
| Other Working Capital | -6,180 | 0 | -1,800 | 0 | 0 |
| Other Operating Activity | 10,020 | 0 | 4,840 | 0 | 0 |
| Operating Cash Flow | $6,250 | $0 | $-10,370 | $0 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -530 | 0 | -850 | 0 | 0 |
| Net Acquisitions | -34,080 | 0 | -13,510 | 0 | 0 |
| Other Investing Activity | 7,800 | 0 | 18,930 | 0 | 0 |
| Investing Cash Flow | $-26,810 | $0 | $4,570 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 29,070 | 0 | 12,820 | 0 | 0 |
| Financing Cash Flow | $29,070 | $0 | $12,820 | $0 | $0 |
| Exchange Rate Effect | -6 | 0 | 70 | 0 | 0 |
| Beginning Cash Position | 16,720 | 0 | 8,940 | 0 | 0 |
| End Cash Position | 25,220 | 0 | 16,040 | 0 | 0 |
| Net Cash Flow | $8,500 | $0 | $7,100 | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,250 | 0 | -10,370 | 0 | 0 |
| Free Cash Flow | 6,250 | 0 | -10,370 | 0 | 0 |